Cargando…
Experience of switching from a daily to a less frequent administration of injection treatments
BACKGROUND: Daily injections of recombinant human growth hormone are the standard of care to treat growth failure due to pediatric growth hormone deficiency (GHD). While effective, daily injections are burdensome and can compromise adherence. In recent years, novel injection treatments requiring les...
Autores principales: | Loftus, Jane, Yaworsky, Andrew, Roland, Carl L., Turner-Bowker, Diane, McLafferty, Megan, Su, Sylvia, Lamoureux, Roger E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710744/ https://www.ncbi.nlm.nih.gov/pubmed/36449502 http://dx.doi.org/10.1371/journal.pone.0278293 |
Ejemplares similares
-
Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
por: Gomez, Roy, et al.
Publicado: (2023) -
Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults
por: Turner-Bowker, Diane M., et al.
Publicado: (2020) -
Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment
por: McNamara, Michelle, et al.
Publicado: (2020) -
PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study
por: Gomez, Roy, et al.
Publicado: (2022) -
Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures
por: Turner-Bowker, Diane M., et al.
Publicado: (2020)